Lunai Bioworks (LNAI) Interest Coverage Ratio (2012 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Interest Coverage Ratio of 13.67 in Q1 2026, up 8.89% quarter-over-quarter from 15.01 in Q4 2025, and up 38.03% on a YoY basis from 9.91 in Q1 2025.
Lunai Bioworks (LNAI) Interest Coverage Ratio (2012 - 2026) Analysis & Trends
Lunai Bioworks' Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 13.67 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 38.03% year-over-year to 13.67; the TTM figure through Mar 2026 stood at 247.28 (down 147.09% YoY), while the FY2025 annual figure was 260.4, down 222.57% from the prior year.
- Interest Coverage Ratio was 13.67 for Q1 2026 at Lunai Bioworks, up from 15.01 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 360.05 in Q2 2022 to a low of 1570.05 in Q4 2022.
- Historically, Interest Coverage Ratio has averaged 162.33 across 5 years, with a median of 45.97 in 2024.
- Biggest YoY gain for Interest Coverage Ratio was 347.56% in 2022; the steepest drop was 2215.89% in 2022.
- A 5-year view of Interest Coverage Ratio shows it stood at 1570.05 in 2022, then jumped by 99.01% to 15.53 in 2023, then tumbled by 196.06% to 45.97 in 2024, then jumped by 67.36% to 15.01 in 2025, then grew by 8.89% to 13.67 in 2026.
- The last three Interest Coverage Ratio figures came in at 13.67 (Q1 2026), 15.01 (Q4 2025), and 27.03 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | -13.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.67 |
| Dec 31, 2025 | -15.01 |
| Sep 30, 2025 | -27.03 |
| Jun 30, 2025 | -675.00 |
| Mar 31, 2025 | -22.06 |
| Dec 31, 2024 | -45.97 |
| Sep 30, 2024 | -213.29 |
| Jun 30, 2024 | -67.54 |
| Mar 31, 2024 | -169.13 |
| Dec 31, 2023 | -15.53 |
| Sep 30, 2023 | -49.56 |
| Jun 30, 2023 | -85.08 |
| Mar 31, 2023 | -33.23 |
| Dec 31, 2022 | -1,570.05 |
| Sep 30, 2022 | -75.23 |
| Jun 30, 2022 | 360.05 |
| Mar 31, 2022 | -42.38 |
| Dec 31, 2021 | -67.79 |
| Sep 30, 2021 | -83.63 |
| Jun 30, 2021 | -145.44 |